Columbus Hill Capital Management L.P. Has $24.83 Million Position in Humana Inc. $HUM

Columbus Hill Capital Management L.P. reduced its stake in Humana Inc. (NYSE:HUMFree Report) by 43.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 96,936 shares of the insurance provider’s stock after selling 75,918 shares during the quarter. Humana makes up 3.5% of Columbus Hill Capital Management L.P.’s investment portfolio, making the stock its 12th largest holding. Columbus Hill Capital Management L.P.’s holdings in Humana were worth $24,828,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Wealthspire Advisors LLC lifted its holdings in Humana by 633.6% in the 4th quarter. Wealthspire Advisors LLC now owns 1,115 shares of the insurance provider’s stock worth $285,000 after purchasing an additional 963 shares during the last quarter. Quadrant Capital Group LLC lifted its holdings in Humana by 88.4% in the 4th quarter. Quadrant Capital Group LLC now owns 1,490 shares of the insurance provider’s stock worth $382,000 after purchasing an additional 699 shares during the last quarter. Empirical Finance LLC lifted its holdings in Humana by 34.0% in the 4th quarter. Empirical Finance LLC now owns 5,969 shares of the insurance provider’s stock worth $1,529,000 after purchasing an additional 1,513 shares during the last quarter. Federation des caisses Desjardins du Quebec lifted its holdings in Humana by 13.9% in the 4th quarter. Federation des caisses Desjardins du Quebec now owns 11,167 shares of the insurance provider’s stock worth $2,859,000 after purchasing an additional 1,360 shares during the last quarter. Finally, DRW Securities LLC acquired a new stake in Humana in the 4th quarter worth approximately $244,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft lowered Humana from a “buy” rating to a “hold” rating in a report on Wednesday, May 20th. Seaport Research Partners lowered Humana to a “neutral” rating in a report on Wednesday, May 20th. Weiss Ratings restated a “sell (d+)” rating on shares of Humana in a report on Tuesday, April 21st. Evercore upped their price target on Humana from $250.00 to $370.00 in a report on Thursday. Finally, TD Cowen upped their price target on Humana from $173.00 to $211.00 and gave the stock a “hold” rating in a report on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, fifteen have given a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $291.35.

Get Our Latest Analysis on HUM

Humana Stock Up 2.9%

Shares of HUM stock opened at $379.42 on Friday. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $379.50. The firm has a market cap of $45.55 billion, a PE ratio of 40.58, a price-to-earnings-growth ratio of 2.10 and a beta of 0.76. The stock has a 50 day moving average of $267.90 and a 200-day moving average of $237.20. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66.

Humana (NYSE:HUMGet Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. During the same period in the previous year, the company earned $11.58 earnings per share. The company’s quarterly revenue was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. On average, equities analysts predict that Humana Inc. will post 9.04 EPS for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. Humana’s payout ratio is 37.86%.

About Humana

(Free Report)

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

See Also

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.